Open access
Jul 2026
A multinational randomized clinical trial of an eye-tracking-based binocular amblyopia treatment in children aged 4-9 years.
Overall, CureSight was noninferior to patching in these amblyopia types and yielded better visual outcomes in children completing ≥ 60% dosage, supporting binocular therapy as an additional first-line option.
O. Yehezkel, T. Wygnanski-Jaffe, B. Kushner et al.
· Scientific Reports · 0 citations